GlassScriptPhysician profile
Humphrey Wong
NPI 1013982610
$31,366.82
in general payments reported to CMS, 2019-2025
49 companies · $11K in 2025
The $11K reported for 2025 was more than what 96% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,118 · 2020: $125 · 2021: $161 · 2022: $788 · 2023: $1,401 · 2024: $16K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Food and Beverage: $5,631 · Education: $4,147 · Travel and Lodging: $3,447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,950.00 |
| Food and Beverage | $5,630.72 |
| Education | $4,146.94 |
| Travel and Lodging | $3,447.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17,670.03 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Intuitive Surgical, INC. | $8,441.55 | 2022-2025 | |
| Insmed, INC. | $772.48 | 2019-2025 | Arikayce, Brinsupri |
| United Therapeutics Corporation | $707.67 | 2019-2025 | Tyvaso, Tyvaso |
| Regeneron Healthcare Solutions, INC. | $400.72 | 2022-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $253.47 | 2019-2024 | Ofev |
| Pfizer INC. | $225.63 | 2019-2025 | |
| Electromed, INC. | $176.46 | 2019-2025 | Smartvest |
| Ani Pharmaceuticals, INC. | $162.59 | 2024 | Purified Cortrophin Gel |
| Takeda Pharmaceuticals U.S.A., INC. | $162.34 | 2022-2025 | Glassia, Hyqvia, Cuvitru |
| Glaxosmithkline, LLC. | $157.99 | 2019-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Healthmyne, INC. | $132.24 | 2019 | |
| Abbott Laboratories | $123.50 | 2022 | |
| Merck Sharp & Dohme LLC | $116.99 | 2019-2024 | Keytruda |
| Ferring Pharmaceuticals INC. | $115.62 | 2023 | Rebyota |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $113.12 | 2019-2024 | Yupelri |
| La Jolla Pharmaceutical Company | $102.62 | 2021 | |
| Mallinckrodt Hospital Products INC. | $100.79 | 2025 | Acthar |
| Abiomed | $98.24 | 2024-2025 | Impella |
| Verona Pharma, INC. | $97.80 | 2025 | Ohtuvayre |
| Genzyme Corporation | $88.31 | 2019 | |
| Amgen INC. | $86.51 | 2019-2024 | Tavneos |
| Allergan, INC. | $84.00 | 2019 | |
| Genmab U.S., INC. | $82.92 | 2024 | Epkinly |
| Ethicon US, LLC | $78.59 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $72.83 | 2022 | |
| Baxter Healthcare | $63.79 | 2024-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Erbe USA INC | $58.83 | 2023-2025 | Cryo2, Erbe Vio3 |
| Mallinckrodt Enterprises LLC | $53.42 | 2019 | |
| Chiesi USA, INC. | $51.90 | 2023 | Cleviprex, Kengreal |
| Alexion Pharmaceuticals, INC. | $43.88 | 2022-2023 | Ultomiris |
| Abbvie INC. | $43.78 | 2023-2025 | Teflaro |
| Ambu INC. | $43.61 | 2024 | |
| Resmed Corp | $42.03 | 2020 | |
| Janssen Pharmaceuticals, INC | $42.01 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.94 | 2022-2025 | |
| Genentech USA, INC. | $36.89 | 2019-2023 | Tecentriq |
| Grifols USA, LLC | $30.44 | 2023-2025 | Prolastin-C Liquid |
| Shire North American Group INC | $27.40 | 2019 | |
| Viatris Specialty LLC | $23.05 | 2025 | Yupelri |
| Sunovion Pharmaceuticals INC. | $22.39 | 2019 | |
| Pulmonx Corporation | $20.10 | 2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Janssen Biotech, INC. | $16.64 | 2019 | |
| Olympus America INC. | $16.19 | 2022 | |
| Edwards Lifesciences Corporation | $15.34 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.26 | 2025 | |
| Seagen INC. | $15.16 | 2020 | |
| Circassia INC. | $12.76 | 2019 | |
| Veran Medical Technologies, INC. | $10.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Humphrey Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.